{"id":"https://openalex.org/W2017830482","doi":"https://doi.org/10.1097/01.coc.0000074165.90133.40","title":"Effect of the Combination of Docetaxel, Zoledronic Acid, and a COX-2 Inhibitor on the Growth of Human Breast Cancer Cell Lines","display_name":"Effect of the Combination of Docetaxel, Zoledronic Acid, and a COX-2 Inhibitor on the Growth of Human Breast Cancer Cell Lines","publication_year":2003,"publication_date":"2003-08-01","ids":{"openalex":"https://openalex.org/W2017830482","doi":"https://doi.org/10.1097/01.coc.0000074165.90133.40","mag":"2017830482","pmid":"https://pubmed.ncbi.nlm.nih.gov/12902864"},"language":"en","primary_location":{"id":"doi:10.1097/01.coc.0000074165.90133.40","doi":"https://doi.org/10.1097/01.coc.0000074165.90133.40","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.coc.0000074165.90133.40","pdf_url":null,"source":{"id":"https://openalex.org/S130927242","display_name":"American Journal of Clinical Oncology","issn_l":"0277-3732","issn":["0277-3732","1537-453X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073311894","display_name":"Lois M. Witters","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130769515","display_name":"Pennsylvania State University","ror":"https://ror.org/04p491231","country_code":"US","type":"education","lineage":["https://openalex.org/I130769515"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lois M. Witters","raw_affiliation_strings":["Penn State College of Medicine, Hershey, Pennsylvania 17033, USA","Illinois","Pennsylvania","U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Penn State College of Medicine, Hershey, Pennsylvania 17033, USA","institution_ids":["https://openalex.org/I130769515"]},{"raw_affiliation_string":"Illinois","institution_ids":[]},{"raw_affiliation_string":"Pennsylvania","institution_ids":[]},{"raw_affiliation_string":"U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068772935","display_name":"Jamie L. Crispino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130769515","display_name":"Pennsylvania State University","ror":"https://ror.org/04p491231","country_code":"US","type":"education","lineage":["https://openalex.org/I130769515"]},{"id":"https://openalex.org/I82783531","display_name":"Penn State Milton S. Hershey Medical Center","ror":"https://ror.org/01h22ap11","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I82783531"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jamie Crispino","raw_affiliation_strings":["From the Penn State College of Medicine (L.M.W., J.C., A.L.), Hershey, Pennsylvania","Pharmacia Pharmaceuticals (T.F.), Skokie, Illinois","and Novartis Pharmaceuticals (J.G.), East Hanover, New Jersey, U.S.A","Illinois","Pennsylvania","U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Penn State College of Medicine (L.M.W., J.C., A.L.), Hershey, Pennsylvania","institution_ids":["https://openalex.org/I130769515","https://openalex.org/I82783531"]},{"raw_affiliation_string":"Pharmacia Pharmaceuticals (T.F.), Skokie, Illinois","institution_ids":[]},{"raw_affiliation_string":"and Novartis Pharmaceuticals (J.G.), East Hanover, New Jersey, U.S.A","institution_ids":[]},{"raw_affiliation_string":"Illinois","institution_ids":[]},{"raw_affiliation_string":"Pennsylvania","institution_ids":[]},{"raw_affiliation_string":"U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059504450","display_name":"Terri Fraterrigo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130769515","display_name":"Pennsylvania State University","ror":"https://ror.org/04p491231","country_code":"US","type":"education","lineage":["https://openalex.org/I130769515"]},{"id":"https://openalex.org/I82783531","display_name":"Penn State Milton S. Hershey Medical Center","ror":"https://ror.org/01h22ap11","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I82783531"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Terri Fraterrigo","raw_affiliation_strings":["From the Penn State College of Medicine (L.M.W., J.C., A.L.), Hershey, Pennsylvania","Pharmacia Pharmaceuticals (T.F.), Skokie, Illinois","and Novartis Pharmaceuticals (J.G.), East Hanover, New Jersey, U.S.A","Illinois","Pennsylvania","U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Penn State College of Medicine (L.M.W., J.C., A.L.), Hershey, Pennsylvania","institution_ids":["https://openalex.org/I130769515","https://openalex.org/I82783531"]},{"raw_affiliation_string":"Pharmacia Pharmaceuticals (T.F.), Skokie, Illinois","institution_ids":[]},{"raw_affiliation_string":"and Novartis Pharmaceuticals (J.G.), East Hanover, New Jersey, U.S.A","institution_ids":[]},{"raw_affiliation_string":"Illinois","institution_ids":[]},{"raw_affiliation_string":"Pennsylvania","institution_ids":[]},{"raw_affiliation_string":"U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100755201","display_name":"Jonathan Green","orcid":"https://orcid.org/0000-0001-8498-1835","observed_orcids":["https://orcid.org/0000-0001-8498-1835"]},"institutions":[{"id":"https://openalex.org/I130769515","display_name":"Pennsylvania State University","ror":"https://ror.org/04p491231","country_code":"US","type":"education","lineage":["https://openalex.org/I130769515"]},{"id":"https://openalex.org/I82783531","display_name":"Penn State Milton S. Hershey Medical Center","ror":"https://ror.org/01h22ap11","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I82783531"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan Green","raw_affiliation_strings":["From the Penn State College of Medicine (L.M.W., J.C., A.L.), Hershey, Pennsylvania","Pharmacia Pharmaceuticals (T.F.), Skokie, Illinois","and Novartis Pharmaceuticals (J.G.), East Hanover, New Jersey, U.S.A","Illinois","Pennsylvania","U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Penn State College of Medicine (L.M.W., J.C., A.L.), Hershey, Pennsylvania","institution_ids":["https://openalex.org/I130769515","https://openalex.org/I82783531"]},{"raw_affiliation_string":"Pharmacia Pharmaceuticals (T.F.), Skokie, Illinois","institution_ids":[]},{"raw_affiliation_string":"and Novartis Pharmaceuticals (J.G.), East Hanover, New Jersey, U.S.A","institution_ids":[]},{"raw_affiliation_string":"Illinois","institution_ids":[]},{"raw_affiliation_string":"Pennsylvania","institution_ids":[]},{"raw_affiliation_string":"U.S.A","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112146037","display_name":"Allan Lipton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130769515","display_name":"Pennsylvania State University","ror":"https://ror.org/04p491231","country_code":"US","type":"education","lineage":["https://openalex.org/I130769515"]},{"id":"https://openalex.org/I82783531","display_name":"Penn State Milton S. Hershey Medical Center","ror":"https://ror.org/01h22ap11","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I82783531"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Allan Lipton","raw_affiliation_strings":["From the Penn State College of Medicine (L.M.W., J.C., A.L.), Hershey, Pennsylvania","Pharmacia Pharmaceuticals (T.F.), Skokie, Illinois","and Novartis Pharmaceuticals (J.G.), East Hanover, New Jersey, U.S.A","Illinois","Pennsylvania","U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Penn State College of Medicine (L.M.W., J.C., A.L.), Hershey, Pennsylvania","institution_ids":["https://openalex.org/I130769515","https://openalex.org/I82783531"]},{"raw_affiliation_string":"Pharmacia Pharmaceuticals (T.F.), Skokie, Illinois","institution_ids":[]},{"raw_affiliation_string":"and Novartis Pharmaceuticals (J.G.), East Hanover, New Jersey, U.S.A","institution_ids":[]},{"raw_affiliation_string":"Illinois","institution_ids":[]},{"raw_affiliation_string":"Pennsylvania","institution_ids":[]},{"raw_affiliation_string":"U.S.A","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5112146037"],"corresponding_institution_ids":["https://openalex.org/I130769515","https://openalex.org/I82783531"],"apc_list":null,"apc_paid":null,"fwci":2.9575,"has_fulltext":false,"cited_by_count":46,"citation_normalized_percentile":{"value":0.91046702,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"26","issue":"Supplement 2","first_page":"S92","last_page":"S97"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.8047000169754028,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.8047000169754028,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.05849999934434891,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.038600001484155655,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9610000252723694},{"id":"https://openalex.org/keywords/zoledronic-acid","display_name":"zoledronic acid","score":1.0},{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.9259999990463257},{"id":"https://openalex.org/keywords/sc-236","display_name":"SC-236","score":0.9279999732971191},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.7419999837875366},{"id":"https://openalex.org/keywords/her-2-neu-overexpression","display_name":"HER-2/neu overexpression","score":0.9470000267028809},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6539999842643738},{"id":"https://openalex.org/keywords/growth-inhibition","display_name":"growth inhibition","score":0.6579999923706055},{"id":"https://openalex.org/keywords/bisphosphonates","display_name":"bisphosphonates","score":0.8190000057220459},{"id":"https://openalex.org/keywords/taxanes","display_name":"taxanes","score":0.9350000023841858},{"id":"https://openalex.org/keywords/additive-drug-effects","display_name":"additive drug effects","score":0.4359999895095825}],"concepts":[{"id":"https://openalex.org/C2776326535","wikidata":"https://www.wikidata.org/wiki/Q218507","display_name":"Zoledronic acid","level":2,"score":0.9399203062057495},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.8763529062271118},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.758751392364502},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.6478897929191589},{"id":"https://openalex.org/C2777251235","wikidata":"https://www.wikidata.org/wiki/Q412205","display_name":"Bisphosphonate","level":3,"score":0.584244966506958},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5302873253822327},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4611961841583252},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4581112265586853},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4496132731437683},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.44062769412994385},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4185701906681061},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.41311758756637573},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.14868399500846863},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12027707695960999},{"id":"https://openalex.org/C2776541429","wikidata":"https://www.wikidata.org/wiki/Q165328","display_name":"Osteoporosis","level":2,"score":0.06613969802856445},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077211","descriptor_name":"Zoledronic Acid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000096926","descriptor_name":"Benzenesulfonamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004164","descriptor_name":"Diphosphonates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007527","descriptor_name":"Isoenzymes","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011451","descriptor_name":"Prostaglandin-Endoperoxide Synthases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014162","descriptor_name":"Transfection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018734","descriptor_name":"Genes, erbB-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051546","descriptor_name":"Cyclooxygenase 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/01.coc.0000074165.90133.40","doi":"https://doi.org/10.1097/01.coc.0000074165.90133.40","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.coc.0000074165.90133.40","pdf_url":null,"source":{"id":"https://openalex.org/S130927242","display_name":"American Journal of Clinical Oncology","issn_l":"0277-3732","issn":["0277-3732","1537-453X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:12902864","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12902864","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of clinical oncology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":38,"referenced_works":["https://openalex.org/W1485442945","https://openalex.org/W1506163818","https://openalex.org/W1521095066","https://openalex.org/W1544157645","https://openalex.org/W1603672218","https://openalex.org/W1815431626","https://openalex.org/W1841504999","https://openalex.org/W1885306047","https://openalex.org/W1911989431","https://openalex.org/W1922272927","https://openalex.org/W1977203209","https://openalex.org/W1986170048","https://openalex.org/W2014184691","https://openalex.org/W2041868422","https://openalex.org/W2043478531","https://openalex.org/W2044240422","https://openalex.org/W2050310941","https://openalex.org/W2050888137","https://openalex.org/W2058526541","https://openalex.org/W2061276429","https://openalex.org/W2074890088","https://openalex.org/W2095156669","https://openalex.org/W2101100140","https://openalex.org/W2107833029","https://openalex.org/W2112336272","https://openalex.org/W2115014494","https://openalex.org/W2141056749","https://openalex.org/W2141393790","https://openalex.org/W2142822079","https://openalex.org/W2143296984","https://openalex.org/W2150253014","https://openalex.org/W2159698605","https://openalex.org/W2169043177","https://openalex.org/W2314428698","https://openalex.org/W2323254708","https://openalex.org/W2326495145","https://openalex.org/W2399681036","https://openalex.org/W2410946992"],"related_works":["https://openalex.org/W2057131948","https://openalex.org/W2128302596","https://openalex.org/W2077383576","https://openalex.org/W2035844944","https://openalex.org/W1989014251","https://openalex.org/W2886801809","https://openalex.org/W2033957216","https://openalex.org/W2101259147","https://openalex.org/W2077985456","https://openalex.org/W1917534569"],"abstract_inverted_index":{"Current":[0],"trends":[1],"in":[2,14,41,54,66,108,126,161,193,202,219,223],"the":[3,20,28,42,55,96,143,166,173,194,203,231],"treatment":[4,56],"of":[5,27,44,57,98,168,175,182,212],"human":[6,45,67,114],"tumors":[7],"are":[8,39],"with":[9,103,165,184,230],"drug":[10],"combinations":[11],"that":[12,34,228],"result":[13],"improved":[15],"responses":[16],"as":[17,19,80,89,91],"well":[18,90],"ability":[21],"to":[22,85,139,148,153,227],"use":[23],"less":[24,137],"toxic":[25],"concentrations":[26],"drugs.":[29],"Recent":[30],"reports":[31],"have":[32],"shown":[33],"COX-2":[35],"inhibitors":[36],"and":[37,63,69,72,112,151,170,172,177],"taxanes":[38],"effective":[40],"suppression":[43],"tumor":[46],"growth.":[47],"The":[48,130,180,209],"bisphosphonate,":[49],"zoledronic":[50,104,140,178,185,214],"acid,":[51],"primarily":[52],"used":[53],"bone":[58],"metastases,":[59],"also":[60,187],"inhibits":[61],"proliferation":[62],"induces":[64],"apoptosis":[65],"breast":[68,115],"prostate":[70],"carcinoma":[71],"multiple":[73],"myeloma.":[74],"HER-2/neu":[75,110,131,204],"overexpression":[76],"has":[77],"been":[78],"suggested":[79],"a":[81,100,109,220],"mechanism":[82],"for":[83],"resistance":[84],"both":[86,127,162],"hormonal":[87],"therapy":[88],"chemotherapy.":[92],"This":[93,197],"study":[94],"examines":[95],"effects":[97],"combining":[99],"cyclooxygenase-2":[101],"inhibitor":[102],"acid":[105,141,186,215],"and/or":[106,216],"docetaxel":[107,169,176,217],"transfected":[111,132,205],"control":[113,144],"cancer":[116],"cell":[117,128,163,207],"line.":[118,196,208],"All":[119],"three":[120],"compounds":[121],"produced":[122],"dose-dependent":[123],"growth":[124,157,224],"inhibition":[125,150,158,225],"lines.":[129],"MCF/18":[133,206],"cells,":[134,146],"however,":[135,199],"were":[136],"sensitive":[138],"than":[142],"MCF/neo":[145,195],"9%":[147],"53%":[149],"18%":[152],"67%,":[154],"respectively.":[155],"Enhanced":[156],"was":[159,200],"observed":[160],"lines":[164],"combination":[167,174,181,211],"SC236":[171,183],"acid.":[179],"gave":[188],"an":[189],"enhanced":[190],"inhibitory":[191],"effect":[192],"combination,":[198],"additive":[201],"triple":[210],"SC236,":[213],"resulted":[218],"small":[221],"increase":[222],"compared":[226],"seen":[229],"double":[232],"combinations.":[233]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}